Unknown

Dataset Information

0

Inhibiting KCNMA1-AS1 promotes osteogenic differentiation of HBMSCs via miR-1303/cochlin axis.


ABSTRACT:

Objective

Osteoporosis is a progressive systemic skeletal disorder. Multiple profiling studies have contributed to characterizing biomarkers and therapeutic targets for osteoporosis. However, due to the limitation of the platform of miRNA sequencing, only a part of miRNA can be sequenced based on one platform.

Materials and methods

In this study, we performed miRNA sequencing in osteoporosis bone samples based on a novel platform Illumina Hiseq 2500. Bioinformatics analysis was performed to construct osteoporosis-related competing endogenous RNA (ceRNA) networks. Gene interference and osteogenic induction were used to examine the effect of identified ceRNA networks on osteogenic differentiation of human bone marrow-derived mesenchymal stem cells (HBMSCs).

Results

miR-1303 was lowly expressed, while cochlin (COCH) and KCNMA1-AS1 were highly expressed in the osteoporosis subjects. COCH knockdown improved the osteogenic differentiation of HBMSCs. Meanwhile, COCH inhibition compensated for the suppression of osteogenic differentiation of HBMSCs by miR-1303 knockdown. Further, KCNMA1-AS1 knockdown promoted osteogenic differentiation of HBMSCs through downregulating COCH by sponging miR-1303.

Conclusions

Our findings suggest that the KCNMA1-AS1/miR-1303/COCH axis is a promising biomarker and therapeutic target for osteoporosis.

SUBMITTER: Lin Y 

PROVIDER: S-EPMC9885668 | biostudies-literature | 2023 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Inhibiting KCNMA1-AS1 promotes osteogenic differentiation of HBMSCs via miR-1303/cochlin axis.

Lin Yuan Y   Dai Hanhao H   Yu Guoyu G   Song Chao C   Liu Jun J   Xu Jie J  

Journal of orthopaedic surgery and research 20230130 1


<h4>Objective</h4>Osteoporosis is a progressive systemic skeletal disorder. Multiple profiling studies have contributed to characterizing biomarkers and therapeutic targets for osteoporosis. However, due to the limitation of the platform of miRNA sequencing, only a part of miRNA can be sequenced based on one platform.<h4>Materials and methods</h4>In this study, we performed miRNA sequencing in osteoporosis bone samples based on a novel platform Illumina Hiseq 2500. Bioinformatics analysis was pe  ...[more]

Similar Datasets

| S-EPMC10685465 | biostudies-literature
| S-EPMC7425508 | biostudies-literature
| S-EPMC11562521 | biostudies-literature
| S-EPMC11344390 | biostudies-literature
| S-EPMC7206728 | biostudies-literature
| S-EPMC6328886 | biostudies-literature
| S-EPMC8418125 | biostudies-literature
| S-EPMC8989710 | biostudies-literature
| S-EPMC3638094 | biostudies-literature